Pathways Pick of the Week: UK Eyes Centralized Licensing
UK floats legislation that could lead to direct MHRA device reviews. Excerpted from Pathways Picks September 2: UK Eyes Centralized Licensing, FDA-SEC Pact, and More.
MedTech Strategist's complimentary Community Blog focuses on the people and the passions that drive the global medical device industry. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.
e-Newsletter BrowseUK floats legislation that could lead to direct MHRA device reviews. Excerpted from Pathways Picks September 2: UK Eyes Centralized Licensing, FDA-SEC Pact, and More.
Medtech investing has maintained its momentum from 2025 through 2026, according to PwC’s latest medtech deals outlook. Excerpted from our recent feature, “As Dollars Chase AI Dream, Investors Stay Grounded.”
New funding from for the agency’s ADVOCATE program. Excerpted from Pathways Picks September 9: FDA Taps Tech Chief, Key Staffer Departs, EU Procurement Reform, and More.
FDA proposes a “competency” framework for regulating generative AI; Excerpted from Pathways Picks August 19: FDA GenAI Plan, Commish Nom, Global Picks, and More.